Mereo BioPharma Group plc Recorded Big Gain
Mereo BioPharma Group plc (MREO:NASDAQ) soared at $1.9, representing a gain of 49.6%. On Mon 01 Jun 20, MREO:NASDAQ touched a New 2-Week Intraday Low of $1.2. The stock got featured on our News Catalysts scanner on Wed 27 May 20 at 07:06 AM in the 'AGREEMENT' category. From Mon 18 May 20, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Fri 27 Dec 19 at $3.74 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About Mereo BioPharma Group plc (MREO:NASDAQ)
Mereo BioPharma Group PLC was incorporated and registered in England and Wales under the name Mereo BioPharma Group Limited on March 10, 2015. On June 3, 2016, the Company re-registered as a public company and changed its name to Mereo BioPharma Group PLC. The Company is a speciality biopharmaceutical company. The Company is principally engaged in the research and development of novel pharmaceuticals.
Top 10 Gainers:
- Precigen, Inc. (PGEN:NASDAQ), 83.33%
- Genius Brands International, Inc. (GNUS:NASDAQ), 53.44%
- Mereo BioPharma Group plc (MREO:NASDAQ), 49.61%
- LATAM Airlines Group S.A. (LTM:NYSE), 37.5%
- IRIDEX Corporation (IRIX:NASDAQ), 34.38%
- Baytex Energy Corp. (BTE:NYSE), 32.88%
- Mmtec, Inc. (MTC:NASDAQ), 32.56%
- MOGU Inc. (MOGU:NYSE), 31.71%
- MoneyGram International, Inc. (MGI:NASDAQ), 29.73%
- Gran Tierra Energy Inc. (GTE:NYSEMKT), 27.05%